Short interest in Lantheus Holdings Inc (NASDAQ:LNTH) decreased during the last reporting period, falling from 6.46M to 6.42M. This put 12.34% of the company's publicly available shares short.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Biotech has been hard hit, as one might expect, leaving many names in bargain territory. Learn why there are opportunities amidst market volatility.

Pictet Asset Management Holding SA boosted its holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 12.1% in ...

Norges Bank acquired a new stake in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) during the 4th quarter, ...

Below is Validea's guru fundamental report for LANTHEUS HOLDINGS INC (LNTH). Of the 22 guru strategies we follow, LNTH rates highest using our Twin Momentum Investor model based on the published ...

Here's a peek at a few of the choices from the screener. Overview: Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products for heart, cancer, and other ...

BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical ...

BEDFORD, Mass. - Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the radiopharmaceutical industry, announced today the completion of its acquisition of Evergreen Theragnostics, Inc., a ...

BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling ...

BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to ...